Synergistische Zusammenarbeit soll altersbedingte Therapien weltweit revolutionieren Geschäft mit einem Wert von über 300 Millionen USD für das erste Produkt MOUNTAIN VIEW, Kalifornien, 29. Mai 2024 /PRNewswire/ — Turn Biotechnologies, ein Entwickler neuartiger mRNA-Medikamente und…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.